Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02154
Species: Homo sapiens
Position : chr16:11075000-11075280
Year: 2025
Title: Defining Mechanistic Links Between the Non-Coding Variant rs17673553 in CLEC16A and Lupus Susceptibility.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: Burkitt lymphoma
PMID:  39796169
MONDO: MONDO:0007243
Tissue: lymph node
Tissue Ontology ID: UBERON:0000029
Cell Source: Namalwa (B-lymphocyte)
CVCL ID: CVCL_0128
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, TF binding assay, Functional perturbation assay
High Throughput Method: ChIP-seq; RNA-seq; Luciferase Reporter Assay
Low Throughput Method: CRISPR Knockout, siRNA Knockdown; RT-RT-qPCR; CRISPRa (dCas9-VPR, dCas9-TET1); CRISPRi (dCas9-DNMT3A, dCas9-MeCP2); Western blot; Luciferase reporter assay; Reporter assay; ChIP-qPCR; qPCR; siRNA knockdown
About Target Gene
Target gene : CLEC16A
About TF
TF name : CTCF
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
CTCF Activation of anterior HOX genes in hindbrain development during early embryogenesis reactome 120
CTCF TGF_beta_Receptor netpath 220
Enhancer Associated Network
Overlapping Enhancers (hg38) 2 found
Enhancer ID Position Tissue Cell Disease
E_02155 chr16:11075000-11075280 lymph node malignant cell Burkitt lymphoma
E_02156 chr16:11075000-11075280 lymph node malignant cell Burkitt lymphoma
Expression of Target Genes for the Enhancer